In September 2025, Medtronic announced it had received FDA approval and launched the Altaviva device, a minimally invasive ...
French biotech EG 427 has had success with its urinary incontinence DNA therapy, EG110A, showing a more than 80% reduction in ...
Implantable biosensors and wearable technologies have the potential to enable continuous, real-time monitoring of kidney and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback